Strengthening research capacity

Chloroquine making a comeback in combatting malaria

16 October 2012

MCDC PhD Student Magatte Ndiaye has published results of his study 'Assessment of the Molecular Marker of Plasmodium falciparum Chloroquine Resistance (Pfcrt) in Senegal after Several Years of Chloroquine Withdrawal'.

For many years Chloroquine was the malaria drug treatment of choice recommended by most African health authorities. However, parasite resistance to the drug over time meant that it was no longer effective. As a result, Ministries of Health began recommending other alternatives such as the now used Artemisinin-based Combination Therapies (ACTs). 

A malaria drug-monitoring study carried out by Magatte and colleagues at the University of Copenhagen has now shown that the previously effective drug Chloroquine is once again beginning to work against malaria. 

Read the full journal article.

The findings have attracted much news interest. Below are links to news coverage of the study:

New Scientist
Yahoo News
Human Health and Science
News Medical (English)
News Medical (Portuguese)

Learn more about mentoring through our Open Access Mentoring Module.

Access the grant system (for MCDC members only)

Follow us:

Contact us

MCDC | London School of Hygiene & Tropical Medicine
Keppel Street